Veterinary Vaccines Market - By Vaccine Type (Livestock Vaccines, Porcine, Poultry And Companion Animal Vaccines), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, And Other Technologies), By Disease (Porcine, Poultry, Livestock, Companion Animal and Aquaculture) and By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, opportunity and Forecast 2020 To 2027
Published Date: May 2021
No. of Pages: 198
Status: Published
Report Code: ARI100610
Livestock diseases are contributing to a set of problems within livestock production systems. These problems include productivity losses, uncertain food security, and loss of income, among others, which are adversely affecting human health. Livestock disease management can reduce disease through the vaccination of animals. Foot-and-mouth disease (FMD) is highly contagious among cloven-hoofed animals, like cattle, swine, sheep, and goats, as well as many species of wild animals. Thus, increasing incidences of livestock diseases are the major factors driving the growth of the veterinary vaccines market, as these diseases can be eradicated with the periodic use of vaccines for animals.
Other factors, which are driving the veterinary vaccines market growth, are rising incidence of zoonotic diseases and initiatives taken by government agencies, animal associations, and leading players.
Veterinary vaccines are used to prevent infectious diseases caused by various causing agents and to provide protection to animals from various life-threatening disorders. Majority of the products are used for immunization of companion animals, ruminants, swine, poultry, and aquaculture. Veterinary vaccination has been proved helpful in the prevention of outbreak of livestock diseases.
An increasing number of pet owners, growing livestock population and disease outbreaks have led to the growth of the global veterinary/animal vaccines market in recent years. However, high storage cost associated with veterinary vaccines is likely to restrain the market growth over the forecast period.
The prominent players in the veterinary vaccines market include Zoetis (US), Merck (US), Boehringer Ingelheim (Germany), Elanco (US), Ceva (France), Phibro Animal Health Corporation (US), and Virbac SA (France). Major players have focused on product launches, agreements, and partnerships to increase their shares in the global veterinary vaccines market.
Boehringer Ingelheim is one of the leading players in the veterinary vaccines market. The company’s leading position can be attributed to its extensive portfolio of veterinary vaccines and a strong geographical footprint. The company operates in over 130 countries across the Americas, Europe, Asia, and Africa. The company’s key advantage over its competitors is that it leverages various opportunities in high-growth and emerging markets, such as Asia, Australia, and Africa. This can be reflected in the company’s strong performance in these markets, which represented over 23.6% of its total revenue in 2018.
Analyst commentary
Rising adoption of companion animals, growing livestock population, and outbreaks of livestock diseases coupled with several advances in technology in veterinary vaccines, and various initiatives by government agencies, animal associations will support the market growth in the forecast period. Recently, in 2017, the number of companion animals consisted of 11 million cats and 26.8 million dogs in China, and 13.1 million dogs and 9.8 million cats in Japan. According to the World Society for the Protection of Animals (WSPA), presently, just 25,000 dogs are living in homes in Republic of Chad, Africa, and 7.4 million dogs and 2 million cats in South Africa.
The disease segment of the market is grouped into companion animal disease, aquaculture diseases, poultry diseases, livestock diseases, and other diseases. The companion animal vaccines segment of the market is expected to grow at a faster rate owing to the growing incidence of zoonotic diseases in humans and the rising pet population
Segmentation
The veterinary vaccines market is segmented based on vaccine type, technology, disease and geography.
By vaccine type, the market is divided into livestock vaccines, Porcine, Poultry and companion animal vaccines.
By technology, the market is divided into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other technologies.
On the basis of disease, the veterinary vaccine market is bifurcated into Porcine, Poultry, Livestock, Companion animal and Aquaculture.
Moreover, by geography, the market is divided into North America, Europe, Asia-Pacific, Middle-East and Africa, and South America.
Regional analysis
The global veterinary vaccines market is segmented into different regions - Americas, Europe, Asia Pacific and the Middle East and Africa. North America holds the largest market share. Veterinary vaccines in the United States are regulated by the Centre for Veterinary Biologics (CVB) in the Animal and Plant Health Inspection Service (APHIS). The CVB grants establishment and product license to animal health companies, in order to manufacture and sell veterinary biologics.
Vaccination, in companion and wildlife animals for zoonotic diseases, had a great impact on reducing the incidence of zoonotic diseases. Furthermore, the rising awareness about the prevention of diseases and technological advancements are expected to propel the demand for veterinary vaccine in the region. The Asia Pacific is expected to grow at the highest rate in the veterinary vaccines market. The major factors driving the growth of this market include the rising pet adoption, expansion of key vaccine players, increasing product availability, and investments in manufacturing facilities in various Asia Pacific countries, especially in India, China, and Thailand.
TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data Component
2.3.1. Secondary Component
2.3.1.1. Preliminary data mining
2.3.2. Primary Component
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Veterinary vaccines Market
Chapter 5. Global Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
5.1. Global Veterinary vaccines Market Share, By Type, 2015 - 2027 (USD Billion)
5.1.1. Porcine Vaccines
5.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.2. Poultry Vaccine
5.1.2.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.3. Livestock Vaccine
5.1.3.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.4. Bovine Vaccines
5.1.4.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.5. Small Ruminant Vaccines
5.1.5.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.5.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.6. Companion Animal Vaccine
5.1.6.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.6.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.7. Canine Vaccine
5.1.7.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.7.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.8. Feline Vaccine
5.1.8.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.8.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.9. Aquaculture Vaccines
5.1.9.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.9.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
5.1.10. Other Animal Vaccines
5.1.10.1. Market Type and Projections,2015 - 2027 (USD Billion)
5.1.10.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 6. Global Veterinary vaccines Market Overview, By Disease, 2015 - 2027(USD Billion)
6.1. Global Veterinary vaccines Market Share, By Disease, 2015 - 2027 (USD Billion)
6.1.1. Porcine
6.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
6.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.2. Poultry
6.1.2.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.3. Livestock
6.1.3.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.4. Bovine
6.1.4.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.5. Small Ruminant
6.1.5.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.5.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.6. Companion Animal
6.1.6.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.6.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.7. Canine
6.1.7.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.7.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.8. Feline
6.1.8.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.8.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
6.1.9. Aquaculture Vaccines
6.1.9.1. Market Type and Projections, 2015 - 2027 (USD Billion)
6.1.9.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 7. Global Veterinary vaccines Market Overview, By Technology, 2015 - 2027(USD Billion)
7.1. Global Veterinary vaccines Market Share, By Technology, 2015 - 2027 (USD Billion)
7.1.1. Live Attenuated Vaccines
7.1.1.1. Market Type and Projections,2015 - 2027 (USD Billion)
7.1.1.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.2. Inactivated Vaccines
7.1.2.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.2.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.3. Toxoid Vaccines
7.1.3.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.3.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.4. Recombinant Vaccines
7.1.4.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.4.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
7.1.5. Other Vaccines
7.1.5.1. Market Type and Projections, 2015 - 2027 (USD Billion)
7.1.5.2. Market Type and Projections, by Region, 2015 - 2027 (USD Billion)
Chapter 8. Global Veterinary vaccines Market Overview, By Geography, 2015 - 2027(USD Billion)
8.1. Global Veterinary vaccines Market Share, By Geography, 2015 - 2027(USD Billion)
8.1.1. Market Type and projections, by Countries, 2015 - 2027 (USD Billion)
8.1.2. Market Share and CAGR Comparison, by Countries, 2020 - 2027 (%)
Chapter 9. North America Veterinary vaccines Market Overview, By Countries, 2015 - 2027(USD Billion)
9.1. North America Veterinary vaccines Market Overview, 2015 - 2027 (USD Billion)
9.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.2. North America Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.3. North America Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
9.1.4. North America Veterinary vaccines Market Overview, By Technology, 2015 - 2027 (USD Billion)
9.1.5. North America Veterinary vaccines Market Overview, By Countries, 2015 - 2027 (USD Billion)
9.1.5.1. U.S. Veterinary vaccines Market Overview, 2015 - 2027 (USD Billion)
9.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.5.1.2. U.S. Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.5.1.3. U.S. Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
9.1.5.1.4. Other Segment
9.1.5.2. Canada Veterinary vaccines Market Overview, 2015 - 2027 (USD Billion)
9.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.5.2.2. Canada Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.5.2.3. Canada Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
9.1.5.2.4. Other Segment
9.1.5.3. Mexico Veterinary vaccines Market Overview, 2015 - 2027 (USD Billion)
9.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
9.1.5.3.2. Mexico Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
9.1.5.3.3. Mexico Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
9.1.5.3.4. Other Segment
Chapter 10. Europe Veterinary vaccines Market Overview, By Countries, 2015 - 2027(USD Billion)
10.1. Europe Veterinary vaccines Market Overview, 2015 - 2027 (USD Billion)
10.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.2. Europe Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
10.1.3. Europe Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
10.1.4. Europe Veterinary vaccines Market Overview, By Technology,2015 - 2027 (USD Billion)
10.1.5. Europe Skin Care Types Market Overview, By Countries, 2015 - 2027 (USD Billion)
10.1.5.1. Germany
10.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.1.2. Germany Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.1.3. Germany Veterinary vaccines Market Overview, By Disease, 2015 - 2027(USD Billion)
10.1.5.1.4. Other Segments
10.1.5.2. France
10.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.2.2. France Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.2.3. France Veterinary vaccines Market Overview, By Disease, 2015 - 2027(USD Billion)
10.1.5.2.4. Other Segments
10.1.5.3. UK
10.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.3.2. UK Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.3.3. UK Veterinary vaccines Market Overview, By Disease, 2015 - 2027(USD Billion)
10.1.5.3.4. Other Segments
10.1.5.4. Italy
10.1.5.4.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.4.2. Italy Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.4.3. Italy Veterinary vaccines Market Overview, By Disease 2015 - 2027(USD Billion)
10.1.5.4.4. Other Segments
10.1.5.5. Spain
10.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Billion)
10.1.5.5.2. Spain Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.5.3. Spain Veterinary vaccines Market Overview, By Disease, 2015 - 2027(USD Billion)
10.1.5.5.4. Other Segments
10.1.5.6. Rest of Europe
10.1.5.6.1. Market Type and projections, 2015 – 2027
10.1.5.6.2. Rest of Europe Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
10.1.5.6.3. Rest of Europe Veterinary vaccines Market Overview, By Disease, 2015 - 2027(USD Billion)
10.1.5.6.4. Other Segments
Chapter 11. Asia Pacific Veterinary vaccines Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1. Asia Pacific Veterinary vaccines Market Overview, 2015 - 2027 (USD Billion)
11.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.2. Asia Pacific Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
11.1.3. Asia Pacific Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
11.1.4. Asia Pacific Veterinary vaccines Market Overview, By Technology,2015 - 2027 (USD Billion)
11.1.5. Asia Pacific Veterinary vaccines Market Overview, By Countries, 2015 - 2027 (USD Billion)
11.1.5.1. India
11.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.5.1.2. India Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.1.3. India Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
11.1.5.1.4. Other Segments
11.1.5.2. China
11.1.5.2.1. Market Type and projections, 2015 - 2027(USD Billion)
11.1.5.2.2. China Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.2.3. China Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
11.1.5.2.4. Other Segments
11.1.5.3. Japan
11.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.5.3.2. Japan Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.3.3. Japan Veterinary vaccines Market Overview, By Disease, 2015 - 2027(USD Billion)
11.1.5.3.4. Other Segments
11.1.5.4. South Korea
11.1.5.4.1. Market Type and projections, 2015 - 2027(USD Billion)
11.1.5.4.2. South Korea Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.4.3. South Korea Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
11.1.5.4.4. Other Segments
11.1.5.5. Rest of Asia Pacific
11.1.5.5.1. Market Type and projections, 2015 - 2027 (USD Billion)
11.1.5.5.2. Rest of Asia Pacific Veterinary vaccines Market Overview, By Type, 2015 - 2027(USD Billion)
11.1.5.5.3. Rest of Asia Pacific Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
11.1.5.5.4. Other Segments
Chapter 12. Middle East & Africa Veterinary vaccines Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1. Middle East & Africa Veterinary vaccines Market Overview, 2015 - 2027 (USD Billion)
12.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.2. Middle East & Africa Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.3. Middle East & Africa Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
12.1.4. Middle East & Africa Veterinary vaccines Market Overview, By Technology,2015 - 2027 (USD Billion)
12.1.5. Middle East & Africa Veterinary vaccines Market Overview, By Countries, 2015 - 2027 (USD Billion)
12.1.5.1. GCC
12.1.5.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.5.1.2. GCC Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.5.1.3. GCC Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
12.1.5.1.4. Other Segments
12.1.5.2. South Africa
12.1.5.2.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.5.2.2. South Africa Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.5.2.3. South Africa Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
12.1.5.2.4. Other Segments
12.1.5.3. Rest of Middle East & Africa
12.1.5.3.1. Market Type and projections, 2015 - 2027 (USD Billion)
12.1.5.3.2. Rest of Middle East & Africa Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
12.1.5.3.3. Rest of Middle East & Africa Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
12.1.5.3.4. Other Segments
Chapter 13. South America Veterinary vaccines Market Overview, By Countries, 2015 - 2027 (USD Billion)
13.1. South America Veterinary vaccines Market Overview, 2015 - 2027 (USD Billion)
13.1.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.2. South America Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
13.1.3. South America Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
13.1.4. South America Veterinary vaccines Market Overview, By Technology,2015 - 2027 (USD Billion)
13.1.5. South America Veterinary vaccines Market Overview, By Countries, 2015- 2026 (USD Billion)
13.1.6. Brazil
13.1.6.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.6.2. Brazil Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
13.1.6.3. Brazil Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
13.1.6.4. Other Segments
13.1.7. Argentina
13.1.7.1. Market Type and projections, 2015 - 2027 (USD Billion)
13.1.7.2. Argentina Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
13.1.7.3. Argentina Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
13.1.7.4. Other Segments
13.1.8. Rest of South America
13.1.8.1. Market Type and projections, 2015 – 2027
13.1.8.2. Rest of South America Veterinary vaccines Market Overview, By Type, 2015 - 2027 (USD Billion)
13.1.8.3. Rest of South America Veterinary vaccines Market Overview, By Disease, 2015 - 2027 (USD Billion)
13.1.8.4. Other Segments
Chapter 14. Competitive Landscape
14.1. Competitive environment, 2020
14.2. Strategic framework
14.2.1. Partnership/agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Type development
Chapter 15. Key Vendor Analysis
15.1. Zoetis
15.1.1. Company overview
15.1.2. Financial performance
15.1.3. Product Benchmarking
15.1.4. Recent initiatives
15.1.5. SWOT analysis
15.2. Merck
15.2.1. Company overview
15.2.2. Financial performance
15.2.3. Product Benchmarking
15.2.4. Recent initiatives
15.2.5. SWOT analysis
15.3. Boehringer Ingelheim
15.3.1. Company overview
15.3.2. Financial performance
15.3.3. Product Benchmarking
15.3.4. Recent initiatives
15.4. Elanco
15.5. Ceva
15.6. Phibro Animal Health Corporation
15.7. Virbac SA
15.8. Ortho Clinical Diagnostics, Inc.
15.9. Becton
15.10. Dickinson and Company
15.11. Novartis AG
Chapter 16. Veterinary vaccines Market Cost Analysis
16.1. Veterinary vaccines Market Key Type Analysis
16.1.1. Key Type
16.1.2. Price Trend of Key Type
16.1.3. Key Suppliers of Type
16.1.4. Market Concentration Rate of Type
16.1.5. Labor Cost
Chapter 17. Sourcing Strategy and Downstream Buyers
17.1. Veterinary vaccines Market Chain Analysis
17.2. Upstream Type Sourcing
17.3. Veterinary vaccines Market Major Manufacturers in 2021
17.4. Downstream Buyers
Chapter 18. Marketing Strategy Analysis, Distributors/Traders
18.1. Marketing Channel
18.1.1. Direct Marketing
18.1.2. Indirect Marketing
18.1.3. Marketing Channel Development Trend
18.2. Market Positioning
18.2.1. Pricing Strategy
18.2.2. Brand Strategy
18.2.3. Target Client
18.3. Distributors/Traders List
Chapter 19. Market Effect Factors Analysis
19.1. Technology Progress/Risk
19.1.1. Substitutes Threat
19.1.2. Technology Progress in Related Type
19.2. Consumer Needs/Customer Preference Change
19.3. Economic/Political Environmental Change
Chapter 20. Future Outlook of the Market
Disclaimer
List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Veterinary vaccines Market share, By Type, 2020 & 2027 (%)
10. Global Veterinary vaccines Market share, by Porcine Vaccines, By Type, 2015 - 2027 (USD Billion)
11. Global Veterinary vaccines Market share, by Poultry Vaccine, By Type, 2015 - 2027 (USD Billion)
12. Global Veterinary vaccines Market share, by Livestock Vaccine, By Type, 2015 - 2027 (USD Billion)
13. Global Veterinary vaccines Market share, by Bovine Vaccines, By Type, 2015 - 2027 (USD Billion)
14. Global Veterinary vaccines Market share, by Small Ruminant Vaccines, By Type, 2015 - 2027 (USD Billion)
15. Global Veterinary vaccines Market share, by Companion Animal Vaccine, By Type, 2015 - 2027 (USD Billion)
16. Global Veterinary vaccines Market share, by Canine Vaccine, By Type, 2015 - 2027 (USD Billion)
17. Global Veterinary vaccines Market share, by Feline Vaccine, By Type, 2015 - 2027 (USD Billion)
18. Global Veterinary vaccines Market share, by Aquaculture Vaccines, By Type, 2015 - 2027 (USD Billion)
19. Global Veterinary vaccines Market share, by Other Animal Vaccines, By Type, 2015 - 2027 (USD Billion)
20. Global Veterinary vaccines Market share, By Disease, 2020 & 2027 (%)
21. Global Veterinary vaccines Market share, by Porcine, By Disease, 2015 - 2027 (USD Billion)
22. Global Veterinary vaccines Market share, by Poultry, By Disease 2015 - 2027 (USD Billion)
23. Global Veterinary vaccines Market share, by Livestock, By Disease 2015 - 2027 (USD Billion)
24. Global Veterinary vaccines Market share, by Bovine, By Disease 2015 - 2027 (USD Billion)
25. Global Veterinary vaccines Market share, by Small Ruminant, By Disease 2015 - 2027 (USD Billion)
26. Global Veterinary vaccines Market share, by Companion Animal, By Disease 2015 - 2027 (USD Billion)
27. Global Veterinary vaccines Market share, by Canine, By Disease 2015 - 2027 (USD Billion)
28. Global Veterinary vaccines Market share, by Feline, By Disease 2015 - 2027 (USD Billion)
29. Global Veterinary vaccines Market share, by Aquaculture Vaccines, By Disease 2015 - 2027 (USD Billion)
30. Global Veterinary vaccines Market share, By Technology, 2020 & 2027 (%)
31. Global Veterinary vaccines Market share, by Live Attenuated Vaccines, By Technology, 2015 - 2027 (USD Billion)
32. Global Veterinary vaccines Market share, by Inactivated Vaccines, By Technology 2015 - 2027 (USD Billion)
33. Global Veterinary vaccines Market share, by Toxoid Vaccines, By Technology 2015 - 2027 (USD Billion)
34. Global Veterinary vaccines Market share, by Recombinant Vaccines, By Technology 2015 - 2027 (USD Billion)
35. Global Veterinary vaccines Market share, by Other Vaccines, By Technology 2015 - 2027 (USD Billion)
36. Global Veterinary vaccines Market share, by region, 2020 & 2027 (%)
37. Global Veterinary vaccines Market share, by region, 2015 - 2027(USD Billion)
38. North America Veterinary vaccines Market, 2015 - 2027(USD Billion)
39. North America Veterinary vaccines Market share, by Countries, 2020 & 2027 (%)
40. U.S. Veterinary vaccines Market, 2015 - 2027(USD Billion)
41. Canada Veterinary vaccines Market, 2015 - 2027(USD Billion)
42. Mexico Veterinary vaccines Market, 2015 - 2027(USD Billion)
43. Europe Veterinary vaccines Market, 2015 - 2027(USD Billion)
44. Europe Veterinary vaccines Market share, by Countries, 2020 & 2027 (%)
45. Spain Veterinary vaccines Market, 2015 - 2027(USD Billion)
46. UK Veterinary vaccines Market, 2015 - 2027(USD Billion)
47. Italy Veterinary vaccines Market, 2015 - 2027(USD Billion)
48. Germany Veterinary vaccines Market, 2015 - 2027(USD Billion)
49. France Veterinary vaccines Market, 2015 - 2027(USD Billion)
50. Rest of Europe Veterinary vaccines Market, 2015 - 2027(USD Billion)
51. Asia-Pacific Veterinary vaccines Market, 2015 - 2027(USD Billion)
52. Asia-Pacific Veterinary vaccines Market share, by Countries, 2020 & 2027 (%)
53. China Veterinary vaccines Market, 2015 - 2027(USD Billion)
54. India Veterinary vaccines Market, 2015 - 2027(USD Billion)
55. Australia Veterinary vaccines Market, 2015 - 2027(USD Billion)
56. Japan Veterinary vaccines Market, 2015 - 2027(USD Billion)
57. Rest of Asia-Pacific Veterinary vaccines Market, 2015 - 2027(USD Billion)
58. Middle East & Africa Veterinary vaccines Market, 2015 - 2027(USD Billion)
59. Middle East & Africa Veterinary vaccines Market share, by Countries, 2020 & 2027 (%)
60. GCC Veterinary vaccines Market, 2015 - 2027(USD Billion)
61. South Africa Veterinary vaccines Market, 2015 - 2027(USD Billion)
62. Rest Of Middle East & Africa Veterinary vaccines Market, 2015 - 2027(USD Billion)
63. South America Veterinary vaccines Market, 2015 - 2027(USD Billion)
64. Brazil Veterinary vaccines Market, 2015 - 2027(USD Billion)
65. Mexico Veterinary vaccines Market, 2015 - 2027(USD Billion)
66. Argentina Veterinary vaccines Market, 2015 - 2027(USD Billion)
67. Rest Of South America Veterinary vaccines Market, 2015 - 2027(USD Billion)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Veterinary vaccines Market, 2015-2027 (USD Billion)
4. Veterinary vaccines requirement, by country, 2015-2027, (USD Billion)
5. North America Veterinary vaccines Market, By Type, 2015-2027 (USD Billion)
6. North America Veterinary vaccines Market, By Disease, 2015-2027 (USD Billion)
7. North America Veterinary vaccines Market, By Technology, 2015-2027 (USD Billion)
8. Europe Veterinary vaccines Market, By Type, 2015-2027 (USD Billion)
9. Europe Veterinary vaccines Market, By Disease, 2015-2027 (USD Billion)
10. Europe Veterinary vaccines Market, By Technology, 2015-2027 (USD Billion)
11. Asia Pacific Veterinary vaccines Market, By Type, 2015-2027 (USD Billion)
12. Asia Pacific Veterinary vaccines Market, By Disease, 2015-2027 (Revenue, USD Billion)
13. Asia Pacific Veterinary vaccines Market, By Technology, 2015-2027 (Revenue, USD Billion)
14. Middle East & Africa Veterinary vaccines Market, By Type, 2015-2027 (USD Billion)
15. Middle East & Africa Veterinary vaccines Market, By Disease, 2015-2027 (USD Billion)
16. Middle East & Africa Veterinary vaccines Market, By Technology, 2015-2027 (USD Billion)
17. South America Veterinary vaccines Market, By Type, 2015-2027 (USD Billion)
18. South America Veterinary vaccines Market, By Disease, 2015-2027 (USD Billion)
19. South America Veterinary vaccines Market, By Technology, 2015-2027 (USD Billion)
20. Global Veterinary vaccines Market, Company Market Share, 2020 - 2027 (%)
21. Zoetis : Deployment model Benchmarking
22. Zoetis : Financial Performance
23. Merck : Deployment model Benchmarking
24. Merck : Financial Performance
25. Boehringer Ingelheim: Deployment model Benchmarking
26. Boehringer Ingelheim : Financial Performance
27. Elanco: Deployment model Benchmarking
28. Elanco: Financial Performance
29. Ceva: Product Benchmarking
30. Ceva: Financial Performance
31. Phibro Animal Health Corporation: Product Benchmarking
32. Phibro Animal Health Corporation Financial Performance
33. Virbac SA: Product Benchmarking
34. Virbac SA: Financial Performance
35. Ortho Clinical Diagnostics, Inc.: Product Benchmarking
36. Ortho Clinical Diagnostics, Inc.: Financial Performance
37. Becton: Product Benchmarking
38. Becton: Financial Performance
39. Dickinson and Company: Product Benchmarking
40. Dickinson and Company: Financial Performance
41. Novartis AG: Product Benchmarking
42. Novartis AG: Financial Performance
The Leading Key Players in Veterinary Vaccines Market
Zoetis (US)
Merck (US)
Boehringer Ingelheim (Germany)
Elanco (US)
Ceva (France)
Phibro Animal Health Corporation (US)
Virbac SA (France).
